Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02386864

Ligand	Ligand name	Chain	PDB	Tanimoto
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.78
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.73
114	COMPACTIN	A,B,C,D	1HW8	0.73
LAN	LANOSTEROL	A	1W6K	0.71
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.75
803	LOVASTATIN	A,B	1CQP	0.75
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.82
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.82
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.82
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.82
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.82
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.81
AXT	ASTAXANTHIN	A,B	1GKA	0.76
0MA	maslinic acid	A	2QN2	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.82
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.82
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.82
C0R	CORTICOSTERONE	A	2A3I	0.9
C0R	CORTICOSTERONE	A,B	1Y5R	0.9
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.85
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.85
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.85
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.85
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.77
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.77
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.77
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.77
TES	TESTOSTERONE	A	1JTV	0.84
TES	TESTOSTERONE	A	2Q7L	0.84
TES	TESTOSTERONE	A	2Q7I	0.84
TES	TESTOSTERONE	A,B	1J96	0.84
TES	TESTOSTERONE	A	2Q7K	0.84
TES	TESTOSTERONE	A,B	1Q13	0.84
TES	TESTOSTERONE	H	1I9J	0.84
TES	TESTOSTERONE	A,B	1AFS	0.84
TES	TESTOSTERONE	H	1VPO	0.84
TES	TESTOSTERONE	A	2Q7J	0.84
TES	TESTOSTERONE	A,B	3BUR	0.84
TES	TESTOSTERONE	A	2AM9	0.84
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.82
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.82
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.82
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.82
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.82
CA4	CYPROTERONE ACETATE	A	2OZ7	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.78
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.78
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.78
AS4	ALDOSTERONE	A	2AA2	0.86
AS4	ALDOSTERONE	A	2Q1H	0.86
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.81
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.72
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.8
0AS	asiatic acid	A	2QN1	0.72
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.82
ERG	ERGOSTEROL	A	1BXM	0.74
ERG	ERGOSTEROL	A	1ZHZ	0.74
ERG	ERGOSTEROL	A,B	2AIB	0.74
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.71
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.71
2OB	CHOLESTERYL OLEATE	A	2OBD	0.72
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.7
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.82
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.71
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.93
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.93
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.74
B2S	(3alpha,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one	A	3B2S	0.7
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.7
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.91
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.71
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.71
CLR	CHOLESTEROL	A,B	2ZXE	0.71
CLR	CHOLESTEROL	A	1N83	0.71
CLR	CHOLESTEROL	A	2RH1	0.71
CLR	CHOLESTEROL	A	1LRI	0.71
CLR	CHOLESTEROL	A	1ZHY	0.71
CLR	CHOLESTEROL	A	3D4S	0.71
ANB	ANDROSTA-1,4-DIENE-3,17-DIONE	A	1H62	0.7
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.73
DEX	DEXAMETHASONE	A,D	1M2Z	0.91
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.91
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.73
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.79
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.76
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.76
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.72
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.84
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.84
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.84